Results 211 to 220 of about 8,174,546 (314)

ESG – A compliance új katalizátora?

A dolgozat központi kutatási kérdése az alábbi: vajon képes-e az ESG újradefiniálni a compliance funkciót stratégiai jelentőségű vállalati eszközzé? Az ennek mentén felállított hipotézis szerint az ESG-kompatibilis megfelelés nemcsak kockázatcsökkentési ...
Szűcs, Györgyi
core  

Real-world treatment compliance and outcomes in adult patients with localized Ewing sarcoma: A single-institution retrospective study. [PDF]

Medicine (Baltimore)
Kalaci E, Kalaci E, Köksoy EB, Akbiyik I, Dursun B, Utkan G.   +5 more
europepmc   +1 more source

Examining the Interchangeability of Two Different Patient‐Reported Global Assessment Measures in an Observational Axial Spondyloarthritis Cohort

Arthritis Care &Research, EarlyView.
Objective The goal of this study was to determine if patient global assessment (PGA) scores reported by patients with axial spondyloarthritis (AxSpA) before the development of the AxSpA Disease Activity Score (ASDAS) can be used as a substitute for the global item of the ASDAS formula.
Connor Vershel, Seokhun Kim, Lianne S. Gensler, Matthew A. Brown, Michael H. Weisman, Mariko L. Ishimori, Michael Ward, John D. Reveille, Mark C. Hwang   +8 more
wiley   +1 more source

Correction: Impact of cardiac rehabilitation and treatment compliance after ST-segment elevation myocardial infarction (STEMI) in France, the STOP SCA+ study. [PDF]

Front Cardiovasc Med
Laurent E, Godillon L, Tassi MF, Marcollet P, Chassaing S, Decomis M, Bezin J, Laure C, Angoulvant D, Range G, Grammatico-Guillon L.   +10 more
europepmc   +1 more source

Prevalence of Dietary Supplement Use and Potential Medication Interactions Among Adults With Systemic Lupus Erythematosus

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to characterize the prevalence and correlates of dietary supplement use, identify commonly used supplements, and evaluate potential supplement–medication interactions among adults with systemic lupus erythematosus (SLE).
Sarah L. Patterson, Russell Ellyson, Jessica Fitzpatrick, Ghizlane Yaakoubi, Bradley Pearce, S. Sam Lim, Jinoos Yazdany, Laura C. Plantinga   +7 more
wiley   +1 more source

Monitoring of immunoglobulin treatment compliance of patients with an inborn error of immunity during the pandemic period. [PDF]

BMC Immunol
Karali Y, Karali Z, Cekic S, Cakir I, Kilic SS.   +4 more
europepmc   +1 more source

Adherence to guidelines, compliance to treatment, and treatment quality

European Heart Journal - Cardiovascular Pharmacotherapy, 2018
openaire   +2 more sources

A Scoping Review and Meta‐Analysis of Proportions of Central Nervous System Manifestations Reported in Patients with Sjögren's Disease

Arthritis Care &Research, EarlyView.
Objective The objective of this scoping review was to synthesize evidence on the proportion of individuals living with Sjögren's disease who experience central nervous system (CNS) manifestations. Methods We searched MEDLINE (via PubMed) and Embase from 1980 through January 29, 2026, and the ECRI Guidelines Trust from 2020 through January 29, 2026 ...
Arun Varadhachary, Ghaith Noaiseh, Julie Frantsve‐Hawley, Frederick B. Vivino, Jennifer A. McCombe, Shamik Bhattacharyya, E. Sherwood Brown, Andrew R. Carey, Robert Fox, Thomas Grader‐Beck, Janet E. Lewis, Stephen Maitz, Steven Mandel, Astrid Rasmussen, George Sarka, R. Hal Scofield, Daniel J. Wallace, Rochelle Zak, Kristie Cox, Katherine M. Hammitt, Steven Carsons, Nancy Carteron   +21 more
wiley   +1 more source

Financial and Treatment Compliance Challenges Among Diabetic Patients: A Cross-Sectional Study From Pakistan. [PDF]

Cureus
Zafar U, Suleman M, Butt MN, Butt SN, Barra TA, Faraz A, Siddique MZ, Aleem M, Iqbal A, Ansar F.   +9 more
europepmc   +1 more source

Real‐World Effectiveness and Safety of Secukinumab in Giant Cell Arteritis: An Italian Multicenter Cohort Study

Arthritis Care &Research, EarlyView.
Objective The objective of this study was to evaluate the real‐world effectiveness and safety of secukinumab in patients with giant cell arteritis (GCA). Methods This multicenter retrospective study included patients with GCA who received secukinumab at 14 Italian centers with at least six months of follow‐up.
Luca Iorio, Federica Davanzo, Caterina Ricordi, Milena Bond, Ruggiero Mascolo, Jacopo Mora, Alessandro Tomelleri, Angelo Fassio, Francesca Cuzzocrea, Sara Monti, Edoardo Conticini, Fabiola Atzeni, Paolo Delvino, Carlotta Nannini, Augusta Ortolan, Francesco Pollastri, Ester Vivaldelli, Chiara Marvisi, Paola Toniati, Antonio Brucato, Alessandra Milanesi, Francesca Regola, Enrico Tombetti, Lorenzo Dagna, Roberta Ramonda, Christian Dejaco, Luca Quartuccio, Carlo Salvarani, Roberto Padoan   +28 more
wiley   +1 more source